RSS   Newsletter   Contact   Advertise with us
Post Online Media

Nanobiotix appoints Alain Dostie as COO

NanobiotixNanobiotix, a late clinical-stage nanomedicine company, announced the appointment of Alain Dostie, a senior executive from the pharmaceutical industry, as its chief operating officer.
Article continues below

READ MORE Nanobiotix adds Laurent Condomine to the board

Previously, Mr. Dostie was the Oncology General Manager at Novartis Germany. He joins Nanobiotix with over 25 years of international experience in the pharmaceutical industry, particularly in market access and oncology.

Prior to joining Nanobiotix, Mr. Dostie served as the Oncology General Manager at Novartis Pharma GmbH in Germany.

Previously, he served within the Novartis group as Oncology General Manager Canada and Oncology Business Unit Head in the Czech Republic and Slovakia.

He also served as Executive Marketing Director and National Sales Director positions in oncology at Novartis Pharmaceuticals Canada, Inc., Government Affairs Manager at Merck Frosst Canada, Inc. and various positions within Bayer Canada Inc. and Millipore Canada during his early career.

Mr. Dostie earned his Bachelor of Science in human kinetics from the University of Guelph, in Ontario, Canada.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy